Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
USA Financial, LLC, American Financial Card, Inc., formerly known as Capitol Financial Inc., et al.
Keystone Holdings, LLC and Compagnie St. Gobain, In the Matter of
The FTC preserved competition in the North American market for alumina wear tile by imposing conditions on Keystone Holdings, LLC and Compagnie de Saint-Gobain in a settlement involving Keystone’s planned acquisition of Saint-Gobain’s Advanced Ceramics Business. According to the FTC’s complaint, the deal as originally structured would have reduced competition in the relevant markets by eliminating direct competition between CoorsTek – the Keystone subsidiary that manufactures its tiles – and Saint-Gobain. In addition, the deal would increase CoorsTek’s market share substantially, eliminate CoorsTek’s most significant alumina wear tile competitor in North America, allow the combined company to raise prices for alumina wear tile, and increase the likelihood that the remaining firms could act together to raise prices for alumina wear tile.
Debt Consultants of America, Inc. and Debt Professionals of America, Inc., et al.
Financial Freedom Processing, Inc., formerly known as Financial Freedom of America, Inc., et al.
Statement of the Commission, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Dissenting Statement of Commissioner Rosch, In the Matter of Laboratory Corporation of America and Laboratory Corporation of America Holdings
Fidelity National Financial, Inc, In the Matter of (LandAmerica Financial)
To settle charges that its 2008 acquisition of three LandAmerica Financial, Inc. subsidiaries was anticompetitive, Fidelity National Financial, Inc. agree to sell several title plants and related assets in six geographic areas: 1) the Portland, Oregon, metropolitan area, consisting of Clackamas, Multnomah, and Washington counties; 2) Benton County, Oregon; 3) Jackson County, Oregon; 4) Marion County, Oregon; 5) Linn County, Oregon; and 6) the Detroit, Michigan, metropolitan area consisting of Oakland, Macomb, and Wayne counties.
International Product Design, Inc.; the Innovation Center, Inc.; National Idea Center, Inc.; New Products of America, Inc.; Azure Communications, Inc. dba London Communications, Inc.; International Licensing Corporation, Inc.
Service Corporation International and Keystone North America Inc., In the Matter of
Service Corporation International (SCI), the nation’s largest provider of funeral and cemetery services, settled Commission charges that its proposed acquisition of Keystone North America Inc., the fifth-largest funeral and cemetery services provider in North America, raises antitrust concerns in several local markets for funeral services and cemetery services. The order requires SCI to sell 22 funeral homes and four cemeteries in 19 local markets to ensure competition is preserved following its acquisition of Keystone.
United States of America (For the Federal Trade Commission), Plaintiff, v. The Talbots, Inc., Defendant
United States of America v. QVC, Inc.
Civic Development Group, LLC, Scott Pasch, and David Keezer., United States of America (for the FTC)
Danaher Corporation and MDS, Inc., In the Matter of
The Commission challenged Danaher’s proposed acquisition of MDS Analytical Technologies, requiring that MDS divest its assets related to its laser microdissection business. The proposed settlement is designed to preserve competition in the North American market for laser microdissection devices – a key tool for scientific research.
Watson Pharmaceuticals, Inc., a corporation, and Robin Hood Holdings Limited, a limited liability company, In the Matter of
The Commission charged that Watson Pharmaceuticals, Inc.’s acquisition of Robin Hood Holdings Limited, owner of Arrow Pharmaceuticals, would have harmed consumers by eliminating future competition for important generic drugs used to treat Parkinson’s disease (cabergoline) and the side effects of chemotherapy (dronabinol). The Commission’s order requires the firms to sell assets related to the two drugs to FTC-approved buyers and to ensure the acquirers have the means to compete effectively in the future.
There is a related federal proceeding and two related administrative proceedings: